+ Follow JOHN DUMPIT Tag
JOHN DUMPIT
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 414032
[Title] => Good news for 'high blood' patients
[Summary] => Tired of your expensive drugs for high blood pressure? Tired of spending your hard-earned money for maintenance medicines? Don’t worry for I’ve found affordable and excellent drugs to control your blood pressure.
[DatePublished] => 2008-11-11 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[1] => Array
(
[ArticleID] => 65625
[Title] => By popular demand: Cheaper medicines for the heart
[Summary] =>
[DatePublished] => 2008-06-03 00:00:00
[ColumnID] => 134789
[Focus] => 0
[AuthorID] => 1805275
[AuthorName] => Dr. Willie T. Ong
[SectionName] => Health And Family
[SectionUrl] => health-and-family
[URL] =>
)
[2] => Array
(
[ArticleID] => 389609
[Title] => PHA holds biggest BP screening in AsPac
[Summary] =>
A total of 101,340 participants from key cities across the country participated in the nationwide blood pressure screening dubbed Presyon Ko Alam Ko, Presyon Ko Alaga Ko last Feb. 11.
The massive turnout made the event the biggest BP screening held in the country and is believed to be the biggest ever BP screening in the Asia-Pacific region.
The current Guinness record is held by United Kingdom with a total of 127,573 individuals participating in the event.
[DatePublished] => 2007-03-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[3] => Array
(
[ArticleID] => 373781
[Title] => Government, private sector unite for more affordable medicines
[Summary] =>
In support of government programs to lower the cost of drugs and President Arroyo’s 10-point agenda for economic recovery, Therapharma Inc., a division of United Laboratories (Unilab), recently launched an affordable and effective brand of amlodipine.
The new amlodipine is being sold at P17.50, or 60 percent more affordable than the prevailing price of the originator brand, which sells at P44.75.
This move by Therapharma is an answer to the government’s call to make effective medicines more affordable for more Filipinos.
[DatePublished] => 2006-12-07 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[4] => Array
(
[ArticleID] => 358054
[Title] => Vidastat: Four years and growing stronger
[Summary] => Therapharma recently celebrated the fourth anniversary of the simvastatin Vidastat, the pharmacoeconomic drug indicated for the treatment and management of dyslipidemia.
Vidastat, which became available in 2002, was one of the first drugs to be launched under the pharmacoeconomics campaign which aims to provide safe, effective and affordable drugs for the treatment of chronic diseases.
[DatePublished] => 2006-09-14 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[5] => Array
(
[ArticleID] => 351899
[Title] => Therapharma marks launch of BP drugs
[Summary] =>
Therapharma, a division of United Laboratories, recently celebrated the anniversary of the launch of its brand of losartan and the losartan and hydrocholorthiazide combination of antihypertensive medicines.
Hypertension is a major risk factor for heart attack and stroke, two of the leading causes of death in the Philippines.
As with other chronic conditions, hypertension requires daily medication to keep the blood pressure within normal range.
[DatePublished] => 2006-08-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[6] => Array
(
[ArticleID] => 319658
[Title] => Glimepiride shown to be effective, safe for diabetes control
[Summary] => Glimepiride has been shown to be an effective and safe medicine in lowering blood sugar, providing a precise blood sugar control without the side-effects often associated with other drugs of the same class known as sulfonylureas.
[DatePublished] => 2006-02-02 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[7] => Array
(
[ArticleID] => 315218
[Title] => Therapharma gives help to World Vision
[Summary] => Therapharma, a division of United Laboratories, recently celebrated the third anniversary of the launch of its brand of simvastatin by joining hands with World Vision, an international Christian organization that sends poor children to school.
John Dumpit, general manager of Therapharma, handed over a check worth P150,000 to broadcast journalist Karen Davila, a World Vision supporter and spokeswoman, representing the company’s donation to the organization’s child sponsorship program.
[DatePublished] => 2006-01-05 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[8] => Array
(
[ArticleID] => 306158
[Title] => Therapharma launches ‘pharmacoeconomic’ glimepiride for diabetes
[Summary] => People with diabetes will now have better access to a medicine that would help lower their blood sugar and reduce the risk of complications brought about by the condition.
Therapharma, a division of United Laboratories, recently launched its brand of glimepiride, an oral medicine belonging to a class of blood sugar-lowering drugs called sulfonylurea.
Glimepiride is used in type II diabetes, the most common type of diabetes that is found in most patients with diabetes.
[DatePublished] => 2005-11-10 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
[9] => Array
(
[ArticleID] => 292152
[Title] => Therapharma’s losartan brand marks first year
[Summary] => Therapharma, a unit of United Laboratories, recently celebrated the first year of its brand of losartan, a medicine for high blood pressure.
Losartan belongs to a new class of antihypertensive medicine called angiotensin receptor blocker (ARB).
According to Dr. Esperanza Cabral, past president of Philippine Society of Hypertension, several studies have shown that losartan is effective in lowering blood pressure and helps delay the onset of kidney problems.
Compared with other types of blood pressure medicines, losartan has lesser side effects of cough and rash.
[DatePublished] => 2005-08-18 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Science and Environment
[SectionUrl] => science-and-environment
[URL] =>
)
)
)
abtest
December 7, 2006 - 12:00am
September 14, 2006 - 12:00am
August 10, 2006 - 12:00am
February 2, 2006 - 12:00am
January 5, 2006 - 12:00am
November 10, 2005 - 12:00am
August 18, 2005 - 12:00am
